Pharmaceutical Resilience
Abstract
Supply chain resilience involves creating diverse and redundant sources for raw materials, optimizing logistics, and employing advanced forecasting techniques to anticipate and mitigate potential shortages. Manufacturing resilience focuses on adopting scalable and adaptable production technologies, enhancing quality control measures, and establishing contingency plans for production disruptions. Regulatory resilience entails the capacity to navigate and comply with evolving regulatory landscapes swiftly, fostering collaborations with regulatory agencies to expedite approval processes during emergencies. Innovation and research resilience are crucial for sustaining drug development and responding to emerging health threats. This involves investing in cutting-edge technologies, fostering partnerships for collaborative research, and maintaining a pipeline of new therapies and treatments. Pharmaceutical resilience also requires effective communication and coordination among stakeholders, including pharmaceutical companies, healthcare providers, governments, and international organizations. By enhancing these components, the pharmaceutical sector can better withstand and recover from disruptions, ensuring continuous access to essential medications and safeguarding public health. This abstract emphasizes the multifaceted approach needed to build and sustain resilience within the pharmaceutical industry, ensuring its capacity to meet both current and future challenges effectively.
Keywords: Supply Chain Management, Regulatory Framework, Research and Development (R&D), Manufacturing Capabilities, Healthcare System Integration, Innovation
Keywords:
Supply Chain Management], Regulatory Framework, Research and Development (R&D), Manufacturing Capabilities, Healthcare System Integration, InnovationDOI
https://doi.org/10.22270/jddt.v14i12.6907References
1. Kamalahmadi M, Shekarian M, Mellat PM. The impact of flexibility and redundancy on improving supply chain resilience to disruptions. Int J Prod Res. 2021:1-29. https://doi.org/10.1080/00207543.2021.1883759
2. Shekarian M, Mellat PM. An Integrative approach to supply chain disruption risk and resilience management: a literature review. Int J Log Res Appl. 2021;24(5):427-55. https://doi.org/10.1080/13675567.2020.1763935
3. Hosseini S, Ivanov D, Dolgui A. Ripple effect modelling of supplier disruption: integrated Markov chain and dynamic Bayesian network approach. Int J Prod Res. 2020;58(11):3284-303. https://doi.org/10.1080/00207543.2019.1661538
4. Fridell M, Edwin S, Von Schreeb J, Saulnier DD. Health system resilience: what are we talking about? A scoping review mapping characteristics and keywords. Int J Health Policy Manag. 2020;9(1):6-16. https://doi.org/10.15171/ijhpm.2019.71 PMid:31902190 PMCid:PMC6943300
5. Alqudah S, Shrouf H, Suifan T, Alhyari S. A moderated mediation model of lean, agile, resilient, and green paradigms in the supply chain. Int J Sup Chain Mgt. 2020;9(4):1-16.
6. Yaroson EV, Breen L, Hou J, Sowter J. Resilience strategies and the pharmaceutical supply chain: the role of agility in mitigating drug shortages. In: Pharmaceutical supply chains-medicines shortages. Cham: Springer; 2019. p. 249-56. https://doi.org/10.1007/978-3-030-15398-4_18
7. Aloosh M, Salavati A, Aloosh A. Economic sanctions threaten population health: the case of Iran. Public Health. 2019;169:10-3. https://doi.org/10.1016/j.puhe.2019.01.006 PMid:30771721
8. Kwon I-W, Kim S-H. Humanitarian supply chain/logistics: roadmap to effective relief effort. J Int Interdiscip Bus Res. 2018;5(1):95-109. https://doi.org/10.58809/YQXZ7481
9. Zhu Q, Krikke H, Caniëls MC. Integrated supply chain risk management: a systematic review. Int J Logist Manag. 2017;28(4):1123-41. https://doi.org/10.1108/IJLM-09-2016-0206
10. Nowell LS, Norris JM, White DE, Moules NJ. Thematic analysis: striving to meet the trustworthiness criteria. Int J Qual Methods. 2017;16(1):1-13. https://doi.org/10.1177/1609406917733847
11. McCrae N, Purssell E. Is it really theoretical? A review of sampling in grounded theory studies in nursing journals. J Adv Nurs. 2016;72(10):2284-93. https://doi.org/10.1111/jan.12986 PMid:27113800
12. Haavisto I, Kovács G, Spens K. Supply chain management for humanitarians: tools for practice: Kogan Page Publishers; 2016.
13. Bahrin NLZ, Hassan Y, Abd Majeed AB, Zulkifli NW, Ahmad A. Pharmaceutical Fiscal Sustainability: Review of Malaysia's Essential Medicines List. 2nd International Conference on Public Policy; Università Cattolica del Sacro Cuore, Milan, Italy 2015.
14. Ochi S, Hodgson S, Landeg O, Mayner L, Murray V. Medication supply for people evacuated during disasters. J Evid Based Med. 2015;8(1):39-41. https://doi.org/10.1111/jebm.12138 PMid:25594870
15. Privett N, Gonsalvez D. The top ten global health supply chain issues: perspectives from the field. Oper Res Health Care. 2014;3(4):226-30. https://doi.org/10.1016/j.orhc.2014.09.002
16. He X, Hu W. Modeling relief demands in an emergency supply chain system under large-scale disasters based on a queuing network. Sci World J. 2014;2014:1-12. https://doi.org/10.1155/2014/195053 PMid:24688367 PMCid:PMC3933051
17. Harrington L, Smith R. The resilient supply chain. DHL Supply Chain. 2014.
18. Aigbogun O, Ghazali Z, Razali R. A framework to enhance supply chain resilience the case of Malaysian pharmaceutical industry. Glob Bus Manag Res. 2014;6(3):219-28.
19. ECD. Guidelines for resilience systems analysis. OECD Publishing Paris; 2014.
20. Bazregar R, Khankeh H, Ahmadi S, Hosseini M, Rahgozar M, Moradian M. The evaluation of application of coordination based disaster response model in Rajaye hospital disaster preparedness. Iran J Nurs Res. 2013;8(29):10-8.
21. Ghatari AR, Mehralian G, Zarenezhad F, Rasekh HR. Developing a model for agile supply: an empirical study from Iranian pharmaceutical supply chain. Iran J Pharm Res: IJPR. 2013;12(Suppl):193.
22. Gupta A, Evans GW, Heragu SS. Simulation and optimization modeling for drive-through mass vaccination-a generalized approach. Simul Model Pract Theory. 2013;37:99-106. https://doi.org/10.1016/j.simpat.2013.06.004
23. Dash SR, Mishra US, Mishra P. Emerging issues and opportunities in disaster response supply chain management. Int J Supply Chain Manag. 2013;2(1):55-61.
24. Chen J, Sohal AS, Prajogo DI. Supply chain operational risk mitigation: a collaborative approach. Int J Prod Res. 2013;51(7):2186-99. https://doi.org/10.1080/00207543.2012.727490
25. Ghatari AR, Mehralian G, Zarenezhad F, Rasekh HR. Developing a model for agile supply: an empirical study from Iranian pharmaceutical supply chain. Iran J Pharm Res. 2013;12(Suppl):193-205.
26. Abdollahiasl A, Jaberidoost M, Farshchi A. PHP13 affordability of antibacterial medicines in Iran during 2001-2010. Value Health. 2012;15(7):A611. https://doi.org/10.1016/j.jval.2012.08.064
27. Ji G, Zhu C. A study on emergency supply chain and risk based on urgent relief service in disasters. Syst Eng Proc. 2012;5:313-25. https://doi.org/10.1016/j.sepro.2012.04.049
28. Gary L. Supply chain resiliency: how prepared is your organization? : Marsh Inc.; 2012.
29. Rachaniotis NP, Dasaklis TK, Pappis CP. A deterministic resource scheduling model in epidemic control: a case study. Eur J Oper Res. 2012;216(1):225-31. https://doi.org/10.1016/j.ejor.2011.07.009
30. Manuj I, Pohlen TL. A reviewer's guide to the grounded theory methodology in logistics and supply chain management research. Int J Phys Distrib Logist Manag. 2012;42(8/9):784-803. https://doi.org/10.1108/09600031211269758
31. Torabizadeh M, Khatami Rad M, Noshadi A. Effect of information system strategies on supply chain strategies and supply chain performance. World Acad Sci, Eng Technol. 2012;61:940-5.
32. Roberts MJ, Reich MR. Last mile logistics for essential drugs: the case of Zambia. In: Roberts M, Reich M, editors. Pharmaceutical reform: a guide to improving performance and equity. Washington, DC: World Bank; 2011. https://doi.org/10.1596/9780821387603_D PMid:21396507 PMCid:PMC5783556
33. Ghanbari V, Maddah S, Khankeh H, Karimloo M. The effect of a disaster nursing education program on nurses' preparedness for responding to probable natural disasters. Iran J Nurs. 2011;24(73):72-80.
34. Bendavid Y, Boeck H. Using RFID to improve hospital supply chain management for high value and consignment items. Proc Comput Sci. 2011;5:849-56. https://doi.org/10.1016/j.procs.2011.07.117
35. Chabner BA. Drug shortages-a critical challenge for the generic-drug market. N Engl J Med. 2011;365(23):2147-9. https://doi.org/10.1056/NEJMp1112633 PMid:22040167
36. Mahendran H, Narasimhan K, Nagarajan N, Gopinath S, editors. Investigation of supply chain risk in the Indian pharmaceutical industry: a case study. Proceedings of the World Congress on Engineering; 2011.
37. Roberts MJ, Reich MR. Last mile logistics for essential drugs: the case of Zambia. In: Roberts M, Reich M, editors. Pharmaceutical reform: a guide to improving performance and equity. Washington, DC: World Bank; 2011. https://doi.org/10.1596/9780821387603_D PMid:21396507 PMCid:PMC5783556
38. Çakıcı ÖE, Groenevelt H, Seidmann A. Using RFID for the management of pharmaceutical inventory-system optimization and shrinkage control. Decision Support Syst. 2011;51(4):842-52. https://doi.org/10.1016/j.dss.2011.02.003
39. Yu X, Li C, Shi Y, Yu M. Pharmaceutical supply chain in China: current issues and implications for health system reform. Health Policy. 2010;97(1):8-15. https://doi.org/10.1016/j.healthpol.2010.02.010 PMid:20307912
40. Brandeau ML, McCoy JH, Hupert N, Holty J-E, Bravata DM. Recommendations for modeling disaster responses in public health and medicine: a position paper of the Society for Medical Decision Making. Med Decis Making. 2009;29(4):438-60. https://doi.org/10.1177/0272989X09340346 PMid:19605887 PMCid:PMC3699691
41. Dong S, Xu SX, Zhu KX. Research note-information technology in supply chains: the value of it-enabled resources under competition. Inf Syst Res. 2009;20(1):18-32. https://doi.org/10.1287/isre.1080.0195
42. Graves S, Lei L, Melamed B, Pinedo M, Qi L, Shen Z, et al., editors. New challenges to emergency management of pharmaceutical/healthcare supply chain disruptions. DHS Workshop on Incident Management, Resource Management, and Supply Chain Management; 2009.
43. Lin Y-H, Batta R, Rogerson A, Blatt A, Flanigan M. Logistic model for delivery of critical items in a disaster relief operation: heuristic approaches2009. 1-42 p.
44. Mosavi G. The preparedness of rehabilitation centers in disasters in Zanjan province. Social Welfare Masters Thesis: University of Social Welfare and Rehabilitation Science; 2008.
45. Jahre M, Heigh I, editors. Does the current constraints in funding promote failure in humanitarian supply chains? Supply Chain Forum: an International Journal; 2008: Taylor & Francis. https://doi.org/10.1080/16258312.2008.11517198
46. Homedes N, Ugalde A. Improving access to pharmaceuticals in Brazil and Argentina. Health Policy Plan. 2006;21(2):123-31. https://doi.org/10.1093/heapol/czj011 PMid:16415339
47. Tang CS. Robust strategies for mitigating supply chain disruptions. Int J Log Res Appl. 2006;9(1):33-45. https://doi.org/10.1080/13675560500405584
48. Hogerzeil HV. Essential medicines and human rights: what can they learn from each other? Bull World Health Organ. 2006;84:371-5. https://doi.org/10.2471/BLT.06.031153 PMid:16710546 PMCid:PMC2627335
49. Christopher M, Peck H. Building the resilient supply chain. Int J Logist Manag. 2004;15(2):1-14. https://doi.org/10.1108/09574090410700275
50. Mclaren TS, Head MM, Yuan Y. Supply chain management information systems capabilities. An exploratory study of electronics manufacturers. Inf Syst E-business Manag. 2004;2(2-3):207-22. https://doi.org/10.1007/s10257-004-0035-5
51. World Health Organization. Equitable access to essential medicines: a framework for collective action. Geneva: World Health Organization; 2004.
52. World Health Organization. How to develop and implement a national drug policy. 2nd ed. Geneva: World Health Organization; 2001
53. Pan American Health Organization. Natural disasters: protecting the public's health. PAHO Washington; 2000.
54. Pan American Health Organization. Natural disasters: protecting the public's health. PAHO Washington; 2000.
55.Christopher M, Jüttner U. Developing strategic partnerships in the supply chain: a practitioner perspective. Eur J Purchasing Supply Manag. 2000;6(2):117-27. https://doi.org/10.1016/S0969-7012(99)00038-6
56. Corbin JM. The Corbin and Strauss chronic illness trajectory model: an update. Sch Inq Nurs Pract. 1998;12(1):33-41.
57. Van der Stuyft P, De Vos P, Hiderbrand K. USA and shortage of food and medicine in Cuba. Lancet. 1997;349(9048):363. https://doi.org/10.1016/S0140-6736(05)62872-3 PMid:9024412
58. Guba EG, Lincoln YS. Competing paradigms in qualitative research. In: Lincoln DYS, editor. Handbook of qualitative research. Thousand Oaks: Sage Publications Inc.; 1994. p. 105-17.
59. Strauss A, Corbin JM. Basics of qualitative research: grounded theory procedures and techniques: Sage Publications Inc.; 1990.
60. Barnett J. Supply of medicines text book of hospital pharmacy. London: Blackwell; 1980. p. 277-330.
Published
Abstract Display: 281 
PDF Downloads: 348 PDF Downloads: 263 How to Cite
Issue
Section
Copyright (c) 2024 Kiran Bhosale , Omkar Baradkar , Sandip Lakade
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.